SK Chemicals Co.,Ltd

KRX:285130.KS

49350 (KRW) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 413,898.117380,960.465431,548.267581,438.774371,335.161364,455.539477,206.03432,545.711501,301.884418,137.698747,713.507527,465.302435,686.157378,766.91321,619.577352,133.136288,408.887252,547.609347,130.731380,452.06380,194.994319,407.825323,503.687376,466.088353,736.646314,012.792
Cost of Revenue 302,318.33299,715.011334,870.713396,235.964281,611.252266,544.066331,444.772279,203.785321,122.181282,325.721369,630.722327,961.665277,085.784233,573.977223,492.708232,565.218214,157.449194,181.252264,890.684292,646.574284,482.095259,155.695261,418.087291,563.944288,980.119253,325.17
Gross Profit 111,579.78781,245.45496,677.554185,202.8189,723.90997,911.473145,761.258153,341.926180,179.702135,811.977378,082.785199,503.637158,600.373145,192.93398,126.869119,567.91874,251.43958,366.35782,240.04787,805.48795,712.89960,252.1362,085.60184,902.14464,756.52760,687.622
Gross Profit Ratio 0.270.2130.2240.3190.2420.2690.3050.3550.3590.3250.5060.3780.3640.3830.3050.340.2570.2310.2370.2310.2520.1890.1920.2260.1830.193
Reseach & Development Expenses 32,141.69827,713.94630,664.59836,056.04336,739.34826,833.66229,159.00227,990.47121,754.21121,316.43622,026.71126,620.87617,914.73919,323.24720,191.48817,020.69314,490.90614,074.85618,774.02215,799.39518,399.31115,152.10318,262.08613,476.81413,325.79914,976.514
General & Administrative Expenses 106,288.3276,358.25,596.988101,843.5416,633.57889,263.8566,974.7096,508.5775,310.3284,120.9534,441.5794,215.924,352.1023,677.5654,256.8483,577.7483,243.2233,543.0935,134.9114,242.0924,309.4884,166.4124,293.3593,841.7883,862.543,747.608
Selling & Marketing Expenses -37,099.11526,038.08922,553.81122,520.11125,664.97923,236.25626,597.79736,422.35432,659.79231,009.126,250.96227,396.42622,401.72519,675.31420,340.47415,804.92213,759.98911,694.49112,489.22617,282.29718,940.00314,398.62219,662.05115,295.87616,587.89616,423.01
SG&A 69,189.21265,553.67960,174.155101,843.54132,298.55789,263.85633,572.50642,930.93137,970.1235,130.05330,692.54131,612.34626,753.82723,352.87924,597.32219,382.6717,003.21215,237.58417,624.13721,524.38923,249.49118,565.03423,955.4119,137.66420,450.43620,170.618
Other Expenses -1,243.729-491.689-589.523-203,687.082-3,448.28-26,929.95138,503.54132,632.22733,176.92230,477.77-13,709.8592,043.4442,870.379-1,493.794-1,176.9471,076.685-2,995.94-779.537-11,950.512-2,096.97594.125-404.9916,190.288-679.942-3,511.429-215.37
Operating Expenses 102,574.63993,759.31491,428.276-101,843.541103,478.99689,167.567101,235.049103,553.62992,901.25386,924.25985,096.43196,342.42172,413.75372,170.49769,818.30867,424.04756,533.43850,253.79663,109.16560,693.35365,497.55256,372.67664,492.1353,940.11854,246.86954,019.126
Operating Income 9,005.148-12,513.865,249.27783,359.269-13,847.1358,647.61722,228.40674,684.46787,192.47548,716.287293,018.631103,063.22286,103.52873,000.5328,308.5652,308.64317,648.7758,017.01519,130.88227,112.13430,438.1193,656.683-2,406.5330,962.02610,509.6576,668.496
Operating Income Ratio 0.022-0.0330.0120.143-0.0370.0240.0470.1730.1740.1170.3920.1950.1980.1930.0880.1490.0610.0320.0550.0710.080.011-0.0070.0820.030.021
Total Other Income Expenses Net -1,016.2231,586.605-14,262.05-5,981.73-10,950.7391,745.04325,554.53-22,892.841-8,603.6669,821.059161,146.366-105,799.4193,131.013-2,224.795-63,924.172-6,493.422-12,642.776-4,244.28-25,713.613-8,131.252-11,876.664-11,767.613-17,048.767-7,881.941-10,042.092-5,599.558
Income Before Tax 7,988.925-10,927.254-9,012.77377,377.539-24,797.87410,392.6647,782.93651,791.62678,588.8158,537.346381,144.58-2,638.20489,317.63370,797.641-35,615.61145,650.4495,075.2253,868.281-6,582.73118,980.88218,338.683-7,888.159-19,455.29723,080.085467.5661,068.938
Income Before Tax Ratio 0.019-0.029-0.0210.133-0.0670.0290.10.120.1570.140.51-0.0050.2050.187-0.1110.130.0180.015-0.0190.050.048-0.025-0.060.0610.0010.003
Income Tax Expense 2,513.807-2,534.89677.70514,886.988-9,329.645-1,054.24-35,683.4629,873.6318,245.67112,789.01127,526.07216.60919,974.62520,294.783-2,604.0589,782.3955,325.158-2,499.996-8,163.01216,312.9545,956.9083,720.2722,866.8216,367.721-5,943.66-1,709.842
Net Income 8,641.575-4,076.975-12,058.86546,866.224-10,626.90411,446.974,369.81734,817.15445,270.89736,808.18893,421.471-27,275.38352,307.10149,686.627-33,334.29635,260.822239,345.75913,048.4841,631.7352,551.46413,446.846-7,032.605-28,491.18518,709.2339,603.3626,206.7
Net Income Ratio 0.021-0.011-0.0280.081-0.0290.0310.1560.080.090.0880.125-0.0520.120.131-0.1040.10.830.0520.0050.0070.035-0.022-0.0880.050.0270.02
EPS 450.31-212.45-628.392,442.19-553.77596.53,875.41,8152,3481,88114,408-929.331,7801,692.67-1,763.11,82412,144658.6781.86127.33686.67-360.67-1,641.93956.67489.33317.33
EPS Diluted 450.31-212.45-628.392,442.19-553.77596.53,875.41,8102,3401,87414,315-929.331,7801,692.67-1,724.971,816.6712,144658.6781.86127.33686.67-360.67-1,641.93956.67489.33317.33
EBITDA 39,321.27122,630.20935,190.703185,202.8120,300.26997,911.47345,974.7797,648.45122,588.00674,531.924301,269.025129,412.393113,986.3293,565.15857,434.82983,037.13341,357.7629,639.86937,825.1347,993.55255,667.3727,549.3724,599.52453,980.16128,530.80929,748.238
EBITDA Ratio 0.0950.0590.0820.3190.0550.2690.0960.2260.2450.1780.4030.2450.2620.2470.1790.2360.1430.1170.1090.1260.1460.0860.0760.1430.0810.095